top of page

Combinib 250 mg Tablet

SKU Cipla Ltd
Precio original

83,86$

Precio de oferta

74,64$

Combinib 250 mg Tablet is a targeted anticancer treatment specifically designed for managing certain types of cancer, most notably breast cancer. As a member of the tyrosine kinase inhibitor class, this medication effectively disrupts the signaling pathways that facilitate the proliferation of cancer cells, thereby hindering tumor growth. Often prescribed in conjunction with other cancer therapies, Combinib enhances the overall effectiveness of a comprehensive treatment plan. While it can significantly improve patient outcomes, it's essential to be aware of potential side effects, which may include gastrointestinal disturbances and fatigue. Regular monitoring by a healthcare professional is crucial to ensure optimal use and to address any adverse reactions promptly. If you are considering Combinib as part of your cancer treatment regimen, consult your healthcare provider to discuss its benefits and any associated risks. This thorough approach allows for a tailored treatment strategy that prioritizes your health and well-being.

Cantidad

Active Pharmaceutical Ingredient

Lapatinib 250 mg

Uses

• Combinib 250 mg tablet is primarily used to manage specific infections caused by bacteria. By targeting the bacteria responsible for the infection, Combinib 250 mg tablet helps to reduce symptoms and promote recovery. It is often prescribed in situations where patients present with moderate to severe bacterial infections. The effectiveness of this medication can significantly improve a patient’s overall health and quality of life.
• In addition to treating infections, Combinib 250 mg tablet may be used in combination with other medications to enhance therapeutic outcomes. This synergistic approach can be particularly beneficial in complex cases where multiple bacterial strains are involved. By utilizing Combinib 250 mg tablet in conjunction with other treatments, healthcare providers can tailor therapy to meet individual patient needs. This ensures a more comprehensive management plan for the patient.
• Combinib 250 mg tablet is also effective in preventing the spread of infection during surgical procedures. Surgeons may prescribe this medication as a prophylactic measure to minimize the risk of postoperative infections. By taking Combinib 250 mg tablet before surgery, patients can help protect themselves from potential complications. This preventive use is a critical aspect of ensuring patient safety during and after surgical interventions.
• Patients with certain chronic conditions may benefit from Combinib 250 mg tablet as part of their long-term management strategy. This medication can help control bacterial overgrowth that might exacerbate existing health issues. Regular use of Combinib 250 mg tablet in these patients can lead to fewer hospital visits and better overall health management. Healthcare providers often monitor these patients closely to assess the effectiveness and adjust treatment as necessary.

Benefits

Lapatinib Tablet helps to treat breast cancer, and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. It relieves the symptoms of breast cancer, such as breast lumps, bloody discharge from nipples, or changes in the shape or texture of the breast. Combinib Breast Cancer Drug kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.

Side Effects

Combinib 250 mg Tablet adverse effects can vary from person to person depending on the severity as well as the immunity. Depending on that, you can have mild, moderate, or severe effects.

Most Common Side Effects

• Vomiting
• Nausea
• Back and Joint Pain
• Headache
• Hair Loss
• Skin dryness and itching
• Breathlessness
• Weakness
• Mouth Ulcers
• Nose Bleeding
• Stomach Pain
• Hot Flushes

Common Side Effects

• Skin Rashes
• Allergic Reactions
• Heart Problems
• Diarrhoea
• Insomnia

How To Use

Combinib 250 mg should be taken exactly as prescribed by your doctor or at least 1 hour before or after taking food. Swallow the tablet and do not crush, open, or dissolve it.

Safety Advice

• Alcohol: It is generally not recommended to drink alcohol while taking Combinib 250 mg. Combinib 250 mg Tablet may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Combinib 250 mg Tablet should be used with caution in patients with kidney disease. Monitoring kidney function while taking Combinib 250 mg, Please consult your doctor for medical advice.
• Breastfeeding: It is not recommended to breastfeed while taking Combinib 250 mg. Combinib 250 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Combinib 250 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Combinib Breast Cancer Drug should be used with caution in patients with severe liver disease. Monitoring liver function while taking Combinib 250 mg: Please consult your doctor for medical advice.
• Pregnancy: Use of Combinib 250 mg Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Combinib 250 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Combinib 250 mg Tablet_four may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Combinib 250 mg.

bottom of page